These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10946410)

  • 1. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
    Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
    New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of human immunodeficiency virus cervicovaginal shedding among postmenopausal and fertile-aged women.
    Melo KC; Melo MR; Ricci BV; Segurado AC
    Menopause; 2012 Feb; 19(2):150-6. PubMed ID: 21983010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
    Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
    J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women.
    Natividad-Villanueva GU; Santiago E; Manalastas RM; Brown HW; Ingersoll J; Caliendo AM; Mayer KH; Cu-Uvin S
    Int J STD AIDS; 2003 Dec; 14(12):826-9. PubMed ID: 14678591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
    Chuachoowong R; Shaffer N; VanCott TC; Chaisilwattana P; Siriwasin W; Waranawat N; Vanprapar N; Young NL; Mastro TD; Lambert JS; Robb ML
    J Infect Dis; 2000 Jun; 181(6):1957-63. PubMed ID: 10837175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
    Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
    J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterovirus RNA shedding in the genital tract of childbearing-aged women living in Central Africa.
    Jacques J; Bélec L; Moret H; Grésenguet G; Longo Jde D; Chomont N; Brodard V; Matta M; Graesslin O; Andréoletti L
    J Med Virol; 2006 May; 78(5):591-7. PubMed ID: 16555273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
    Coombs RW; Wright DJ; Reichelderfer PS; Burns DN; Cohn J; Cu-Uvin S; Baron PA; Cohen MH; Landay AL; Lewis S; Kovacs A;
    J Infect Dis; 2001 Nov; 184(9):1187-91. PubMed ID: 11598843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
    Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
    J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.
    Bard E; Riethmuller D; Biichlé S; Meillet D; Prétet JL; Mougin C; Seillès E
    J Immunoassay Immunochem; 2002; 23(2):145-62. PubMed ID: 12033640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
    Haimovici F; Mayer KH; Anderson DJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
    Mestecky J; Wright PF; Lopalco L; Staats HF; Kozlowski PA; Moldoveanu Z; Alexander RC; Kulhavy R; Pastori C; Maboko L; Riedner G; Zhu Y; Wrinn T; Hoelscher M
    AIDS Res Hum Retroviruses; 2011 May; 27(5):469-86. PubMed ID: 21091128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
    Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
    J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy.
    Schneider JA; Alam SA; Ackers M; Parekh B; Chen HY; Graham P; Gurwith M; Mayer K; Novak RM
    J Infect Dis; 2007 Dec; 196(11):1637-44. PubMed ID: 18008247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.